Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
Condition(s):Mixed GliomasLast Updated:January 17, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Mixed GliomasLast Updated:January 17, 2018Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:September 12, 2019Completed
Condition(s):Central Nervous System Tumors; Brain TumorLast Updated:September 18, 2018Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:October 22, 2020Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 18, 2018Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:September 24, 2012Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:February 20, 2024Recruiting
Condition(s):Brain and Central Nervous System TumorsLast Updated:October 12, 2016Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 14, 2022Completed
Condition(s):Adult Anaplastic Oligodendroglioma; Adult Mixed Glioma; Adult Oligodendroglioma; Recurrent Adult Brain NeoplasmLast Updated:October 21, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.